Loading clinical trials...
Loading clinical trials...
Safety, Compatibility and Imaging Quality of ExAblate Prostate Applicator for Prostate Cancer
Evaluate the safety, compatibility and imaging quality of the ExAblate MRgFUS system.
The objective of this study is to evaluate safety, compatibility and imaging quality of the ExAblate MRgFUS system for prostate cancer, under simulated use conditions. No acoustic energy will be delivered and no focused ultrasound therapy will be performed. This is an imaging only study.
Age
0 - 75 years
Sex
MALE
Healthy Volunteers
No
Sheba Medical Center
Tel Litwinsky, Israel
Start Date
January 1, 2009
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
March 8, 2016
10
ESTIMATED participants
ExAblate MRgFUS for prostate cancer
DEVICE
Lead Sponsor
InSightec
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494